About

Aims and scope

Thorax is one of the world’s leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax seeks to publish significant advances in scientific understanding, which are likely to impact on clinical practice. This includes articles concerning basic and translational mechanisms with application to clinical material (cell and molecular biology, genetics, epidemiology, and immunology).

Editorial Board

For information about the Thorax editorial team and the three joint Editors-in-Chief Nicolas Hart, Gisli Jenkins and Alan Smyth, please refer to the Editorial Board page.

Ownership

Thorax is co-owned by the British Thoracic Society and BMJ.

Journal information

Publication Model Subscription; with hybrid open access option
Frequency Monthly
Launch date 1946
Indexed by Index Medicus (Medline), Science Citation Index, ISI Current Contents (Clinical Medicine/Life Sciences), Excerpta Medica (Embase), BIOSIS Previews
Impact Factor 8.272
Peer Review Model Single blind; the names of reviewers are hidden from the author
Print ISSN 0040-6376
Online ISSN 1468-3296

Journal statistics

Acceptance Rate 8%
Instant Rejection Rate 66%
Time to Submission to First Decision 14 days
Time to Acceptance to Publication 20 days

Contact information

For all contact information please refer to the Contact Us page.

For authors

Please refer to the Instructions for Authors.

Subscriptions

To advertise

Rights and permissions

Affiliations

Thorax is provided as a benefit to members of the British Thoracic Society (BTS).

COPE logo

BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues relating to the integrity of the work submitted to or published in their journals.

Equator

The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. The BMJ Group is a sponsor of its activities.

AllTrials logo

BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.

Related BMJ sites